Gram Negative Bacterial Inflammation Ameliorated by the Plasma Protein Beta 2-Glycoprotein I
Saijun Zhou(Hunan University of Science and Technology), Bill Giannakopoulos(Sutherland Hospital), Julia Beretov(St George Hospital), Fatima El‐Assaad(Sutherland Hospital), James Weaver(Janssen (United States)), Ying Wang(Sun Yat-sen University), Gang Chen(Fudan University), Liming Chen(Tianjin Medical University), Shangwen Dong(Huazhong University of Science and Technology), De-min Yu(Tianjin Medical University), Miao Qi(Sutherland Hospital), Steven A. Krilis(Brigham and Women's Hospital)
Cited by 34
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
FDA Drug Approval Summary: Gefitinib (ZD1839) (Iressa®) Tablets
|The Oncologist|2003|576
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
|PubMed|2002|469
Bone marrow–on–a–chip replicates hematopoietic niche physiology in vitro
|Nature Methods|2014|450